Antiviral Therapy and Hepatitis B Reactivation Outcomes in Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors: A Retrospective Cohort Study

Objectives: Viral Hepatitis reactivation can occur in patients receiving tyrosine kinase inhibitors (TKIs), with potentially fatal complications. We aimed to assess hepatitis reactivation in patients with chronic myeloid leukemia (CML) treated with TKIs. Methods: We retrospectively reviewed the clin...

Descripción completa

Detalles Bibliográficos

Autores principales:	Salam Al Kindi, Shahla S. A Al-Jabri, Anil Pathare, Shoaib Al-Zadjali, Mohamed Al-Rawahi, Giuseppe Saglio
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Oman Medical Specialty Board 2026-01-01
Colección:	Oman Medical Journal
Materias:	chronic myeloid leukemia tyrosine kinase inhibitors prevalence antiviral agents hepatitis b hepatitis c oman
Acceso en línea:	https://www.omjournal.org/articleDetails.aspx?coType=1&aId=4138
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!